공고 • Jul 10
VEON Ltd. Receives Extension by Nasdaq for 20-F Filing VEON Ltd. confirmed that Nasdaq has accepted the Company’s plan submitted May 29, 2024 to regain compliance in connection with the delayed filing of its Annual Report on Form 20-F for the year ended December 31, 2023. Nasdaq has granted the Company an exception, enabling it to regain compliance with the listing rules by filing its 2023 20-F on or before November 11, 2024. VEON had previously reported that it would be delayed in its filing of its 2023 20-F due to extraordinary circumstances related to the war in Ukraine and the sale of its Russian operations which impacted its ability to appoint an independent Public Company Accounting Oversight Board (“PCAOB”) registered audit firm; and announced that it had received notice from Nasdaq that it was not in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). Since that time, the Company has also announced it has appointed UHY LLP (“UHY”) as its PCAOB auditors for the 2023 20-F. The Company’s plan to regain compliance has now been accepted by the Listing Qualifications Department of The Nasdaq Stock Market, which granted the Company an exception for its delayed 2023 20-F filing. The Company confirms that, as previously announced, it continues to work diligently together with UHY in order to complete and file its 2023 20-F in the fourth quarter of 2024. 공고 • May 03
VEON Ltd. announced delayed 20-F filing On 05/01/2024, VEON Ltd. announced that they will be unable to file their next 20-F by the deadline required by the SEC. 공고 • Jun 14
VEON Granted Extension by Nasdaq for 20-F Filing VEON Ltd. confirmed that Nasdaq has accepted the Company’s plan submitted May 8,2023 to regain compliance in connection with the delayed filing of its Annual Report on Form 20-F for the year ended December 31, 2022. Nasdaq has granted the Company an exception, enabling it to regain compliance with the listing rules by filing its 2022 20-F by October 30, 2023. VEON had previously reported that it would be delayed in its filing of 2022 20-F due to extraordinary circumstances in 2022; and announced that it had received notice from Nasdaq that it was not in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). The Company’s plan to regain compliance, shared with Nasdaq in the days following the notice, was accepted by the Listing Qualifications Department of The Nasdaq Stock Market, which granted the Company an exception for delayed filing. The Company confirms that, as previously announced, it continues to work diligently together with its independent external auditor in order to complete and file its 2022 20-F as soon as possible. 공고 • May 08
VEON Receives Nasdaq Notice on Delayed Filing of 2022 Annual Report VEON Ltd. confirmed that on May 3, 2023 it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 20-F for the year ended December 31, 2022 (the “2022 20-F”) as indicated in the Company’s Notification of Late Filing on Form 12b-25 filed with the with the U.S. Securities and Exchange Commission on May 2, 2023, the Company is not in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). As the Company has previously reported in its Notification of Late Filing, due to extraordinary circumstances it was not able to engage an independent auditor for the year ended December 31, 2022 on a normal timeframe, and has recently confirmed the appointment of its independent external auditor for 2022. As a result, VEON is unable to file its Form 20-F within the prescribed time as VEON requires additional time to complete VEON’s consolidated financial statements, and, subsequently, receive the related audit report on the financial statements and internal control over financial reporting. The Company has also submitted on May 08, 2023 to Nasdaq its plan to regain compliance, which includes working diligently together with its independent external auditor in order to complete and file its 2022 20-F. Following submission of the Company's plan to Nasdaq, Nasdaq may grant the Company an exception of up to 180 calendar days from the due date, or until October 30, 2023, to regain compliance. The notification has no immediate effect on the continued listing status of VEON’s American Depositary shares (“ADSs”) on Nasdaq and its ADSs will continue to trade on The Nasdaq Capital Market. Furthermore, VEON’s business operations are not affected by the receipt of the notification.